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Providing adequate vascularization is one of the main hurdles to the widespread clinical application of
bone tissue engineering approaches. Due to their unique role in blood vessel formation, endothelial
cells (EC) play a key role in the establishment of successful vascularization strategies. However,
currently available polymeric materials do not generally support EC growth without coating with
adhesive proteins. In this work we present argon plasma treatment as a suitable method to render the
surface of a 3D starch-based scaffold compatible for ECs, this way obviating the need for protein pre-
coating. To this end we studied the effect of plasma modification on surface properties, protein
adsorption and ultimately on several aspects regarding EC behaviour. Characterization of surface
properties revealed increased surface roughness and change in topography, while at the chemical level
a higher oxygen content was demonstrated. The increased surface roughness of the material, together
with the changed surface chemistry modulated protein adsorption as indicated by the different
adsorption profile observed for vitronectin. In vitro studies showed that human umbilical vein ECs
(HUVECs) seeded on plasma-modified scaffolds adhered, remained viable, proliferated, and
maintained the typical cobblestone morphology, as observed for positive controls (scaffold pre-coated
with adhesive proteins). Furthermore, genotypic expression of endothelial markers was maintained and
neighbouring cells expressed PECAM-1 at the single-cell-level. These results indicate that Ar plasma
modification is an effective methodology with potential to be incorporated in biomaterial strategies to
promote the formation of vascularized engineered bone.
1. Introduction
During its 15 years of existence the tissue engineering field has
evolved greatly and important milestones have been achieved.1
However, despite the major advances this field has brought, the
lack of vascular supply remains the holy grail and the main
hurdle to the clinical application of large constructs. When in
vitro engineered cellular constructs are transferred in vivo, they
have to rely on processes, such as interstitial fluid diffusion and
blood perfusion to cover their metabolic demands.2 Theoretical
modeling studies predict hypoxia and central necrosis in almost
any graft site with a diffusion distance of more than 500 to 1000
mm.3 Therefore, a successful engineered-construct must be sup-
ported by a dense capillary network connected to the microcir-
culation at the implantation site, supplying perfusion for
adequate oxygenation and nutrition, as well as removal of waste
products from the corresponding tissues.
In the particular case of bone, a functional vascular network is
more than just simple conduits that ensure cellular metabolic
requirements. Its importance is already manifested in bone
ontogeny, where angiogenesis precedes osteogenesis and
continues during bone process repair.4 Furthermore, initial
vascularization may be essential for enhanced engraftment and
prevention of infections.2 For these reasons, induction of
vascularization is an integral element of any successful bone
tissue engineering concept. Several strategies have been proposed
to accelerate vascularization in engineered bone. Hybrid
approaches, combining tissue engineering with microvascular
surgical techniques such as free bone flap5 and pedicle bone flap
transplantation,6 have been described. Nevertheless, these
methods are associated with several major drawbacks such as the
need for a donor site, creation of a soft-tissue donor-site defect
and the consequent patient inconvenience in the clinical
setting.5,7 The localized or systemic application of angiogenic
growth factors has also been one of the most popular strategies.8
Delivery systems releasing a single angiogenic growth factor9
have been upgraded into multi-phasic delivery systems,10 able to
promote the formation of more stable vessels. However, these
systems can only be regarded as an adjuvant of vascularization
orchestration. As ECs are the main cellular mediator of neo-
vascular growth several approaches for vascularized engineered-
bone involving this cell type have been explored. Strategies
involving bulk culturing of mature ECs,11 progenitor cells12 or
ECs combined with other cell types such as osteoblasts13 can be
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found in the literature. It is expected that in the in vivo envi-
ronment ECs migrate out from the tissue-engineered construct
into the implantation site, form networks of capillaries and gain
access to the recipient’s circulation.2,7 Hence, whether relying on
an extrinsic or intrinsic blood supply, the adopted neo-
vascularization approach will always have, directly or indirectly,
ECs as target cell type. Therefore, it is of ultimate importance
that the 3D construct is compatible with this cell type.
It is rare that a biomaterial with adequate bulk properties also
possesses the surface characteristics suitable for clinical appli-
cation14 and this is particularly true for ECs because most of the
proposed polymeric substrates do not support their adhesion and
growth. A common approach is to fabricate biomaterials with
appropriate bulk properties and to modify those by specific
treatments resulting in enhanced surface properties.15 Surface
modification techniques for three-dimensional (3D) polymeric
structures include different wet chemical treatments such as
grafting, attaching cell-recognizing ligands or more aggressive
methods such as soaking in oxidative or hydrolytic baths.
However, a lack of reactive groups on the polymer backbones
and/or interactions between the solvents and the modified
materials, also leading to bulk modification, are very often
obstacles to the use of these methods. Hence, some research has
been focused on coating of scaffolds with extracellular matrix
proteins in order to increase cell adhesion to the surface.16,17
Although this approach overcomes the difficulties related with
the wet-based treatments, protein adsorption is a difficult process
to control and its stability with time is problematic.18 Plasma
surface modification has only recently been considered as an
alternative route to enhance the surface biocompatibility of 3D
polymer-based structures.19,20 The difficulties in modification of
scaffolds by plasma are enhanced by the requirement for highly
porous and interconnected samples. Therefore, application of
different plasma surface modification has been limited to various
polymer membranes and 2D bulk structures.
In this work, fiber-mesh scaffolds made from a blend of starch
with polycaprolactone (SPCL) that were previously proposed for
bone engineering scaffolding,21–24 have been modified by means
of argon (Ar) plasma treatment. This method was applied to
tailor the surface of SPCL scaffold to promote EC adhesion and
proliferation, and thus obviate the need for protein pre-coating.
To our knowledge this is the first report on an efficient plasma
surface modification of a 3D natural-based construct for tissue
engineering applications. The effect of plasma treatment at the
surface properties level and its influence on the adsorption of
adhesive proteins were assessed. Furthermore, the ultimate
benefits of plasma-modified SPCL fiber-mesh scaffolds were
evaluated by assessing EC biological responses, namely adhe-
sion, proliferation profile and genotypical/phenotypical expres-
sion of endothelial markers.
2. Materials and methods
2.1. Scaffolds
Scaffolds produced from a blend of starch with polycaprolactone
(SPCL, 30/70 wt%) were used for this study. SPCL fiber-mesh
scaffolds were obtained by a fiber-bonding process consisting of
spinning, cutting and sintering melt-spun fibers, as previously
described.21,22,25 The samples were cut into discs with 8 mm
diameter and 2 mm height and sterilized by ethylene oxide.
2.2. Plasma surface modification
The surface treatment was performed using a plasma reactor
PlasmaPrep5 (Gala Instrument GmbH, Germany) with a fully
automated process control. Argon was used as a working gas and
the pressure in the reactor was controlled (0.18 mbar) by
adjusting the flow rate. Prior to treatment, the chamber was
purged with argon five times. A radio frequency source (13.56
MHz) was used and a power of 30Wwas applied for 15 min. The
samples were kept at air atmosphere after being removed from
the reactor.
2.3. Surface characterization and protein adsorption
Scanning electron microscopy (SEM). The surface morphology
of SPCL fibers was analysed by a Leica Cambridge S360 scan-
ning electron microscope (SEM) before and after plasma treat-
ment. The samples were previously sputter-coated with gold in
an ion sputter chamber (JEOL JFC 1100). Microphotographs at
the surface were taken at various magnifications.
Optical profiler analysis. Optical profilometry is a non-contact
method which allows roughness analysis of 3D structures with
high resolution from subnanometer to millimetre step-height. In
this study an optical profiler Wyko NT 3300 from Veeco
Instruments Inc. was used. The measurements were performed in
Vertical Scanning Interferometry (VSI) mode and an area of 2
mm was analysed with a vertical resolution of 3 nm.
X-Ray photoelectron spectroscopy (XPS). XPS was used to
determine the elemental surface composition of treated and
untreated samples. The analysis was carried out using the
instrument VG Escalab 250 iXL (VG Scientific, UK). The
measurements were performed with monochromatic Al-Ka
radiation (hn ¼ 1486.6 eV) in a constant analyzer energy mode
(CAE) with 100 eV pass energy for survey spectra and 20 eV pass
energy for high-resolution spectra. Photoelectrons were collected
from a take-off angle of 90" relative to the sample surface.
Charge referencing was adjusted by setting the lower binding
energy C1s hydrocarbon (CHx) peak at 285.0 eV. Surface
elemental composition was determined by standard Scofield
photoemission cross sections. The identification of the chemical
functional groups was obtained from the high-resolution peak
analysis of C1s envelopes by XPSPEAK 4.1 software.
Time-of-flight secondary ion mass spectrometry (TOF-SIMS).
Detailed quantitative analysis of the surface composition before
and after plasma modification was obtained by TOF-SIMS. The
mass spectra of the samples were recorded on a TOF-SIMS IV
instrument from Ion-TOF GmbH Germany. The samples were
bombarded with a pulsed bismuth ion beam (25 keV) at 45"
incidence over an area with size 100 mm2. The generated
secondary ions were extracted with a 10 kV voltage and their
time of flight from the sample to the detector was measured in
a reflection mass spectrometer.
4092 | J. Mater. Chem., 2009, 19, 4091–4101 This journal is ª The Royal Society of Chemistry 2009
Do
wn
loa
de
d b
y U
niv
ers
ida
de
 do
 M
inh
o (
UM
inh
o) 
on
 11
 N
ov
em
be
r 2
01
0
Pu
bli
sh
ed
 on
 31
 M
arc
h 2
00
9 o
n h
ttp
://p
ub
s.r
sc.
org
 | d
oi:
10
.10
39
/B
81
90
89
E
Contact angle measurements. Surface wettability was evaluated
by static contact angle measurements on 2D samples prepared by
a procedure similar to the one used for the scaffolds, i.e. by
polymer melting with subsequent injection into a mould. Prior to
measurements, the samples were plasma modified at the same
conditions used for the scaffolds. The values were obtained by
a sessile drop method using a contact angle meter OCA15+ with
a high-performance image processing system from DataPhysics
Instruments, Germany. The used liquid (H2O, 1 mL, HPLC
grade) was added by a motor driven syringe at room tempera-
ture. Five samples of each material were used and six measure-
ments per sample were carried out. The normality of the data was
checked by applying the Shapiro–Wilk W-test. Since all the
samples followed a normal distribution, Student’s t-tests for
independent samples were performed to test differences.
Throughout the following discussion differences were considered
significant if p < 0.05, and highly significant if p < 0.01. The
statistical analysis was performed with the package Statistica 6.0
(StatSoft, USA).
Protein adsorption: Immunolabelling and confocal laser scan-
ning microscopy (CLSM). The effect of plasma treatment on the
adsorption of fibronectin (Fn) and vitronectin (Vn) from the cell
culture media was investigated using CLSM in combination with
fluorescent immunolabelling methodology. The protein system
used in this studywas amulti-protein solution of 20% (v/v) of fetal
calf serum (Sigma, Germany) in M199 medium (Sigma, Ger-
many). Untreated and plasma treated SPCL scaffolds were
immersed in this solution and incubated for 1 h at 37 "C. Samples
immersed in phosphate buffered saline solution (PBS) were used
as blanks.Then, sampleswere fixed in a 2.5% formalin solution for
5 min and washed with PBS solution. Afterwards, samples were
incubated with primary antibody mouse anti-human fibronectin
with calf cross-reactivity (1 : 50, Sigma, Germany) or mouse anti-
bovine anti-vitronectin (1 : 50, Santa Cruz, USA). After washing
with PBS, materials were incubated with goat anti-mouse Alexa
Fluor 488 secondary antibody (Invitrogen, USA), for 1 h at RT.
Labelled samples were analysed by CLSM (Olimpus IX81).
2.4. Cell culture and scaffold seeding
Primary endothelial cells (ECs) derived from the umbilical cord
vein (HUVECs) were used for cell culture studies. The cells were
isolated from the umbilical vein by collagenase solution. Further
details about the procedure can be found elsewhere.26 HUVECs
were cultured in M199 medium supplemented with 20% fetal calf
serum, 1% penicillin/streptomycin, 25 mg mL#1 endothelial cell
growth supplement (BD Bioscience, USA) and 2 mM Glutamax
I (Gibco, Germany). Cells were cultured in culture flask previ-
ously coated with 0.2% gelatine (Sigma, Germany).
Prior to cell seeding SPCL fiber-mesh scaffolds were soaked
overnight in culture medium without serum. Untreated scaffolds
pre-coatedwith 10 mgmL#1 fibronectin in PBS (Roche, Germany)
for 1 h at 37 "C were used as positive control since this is
a standard procedure to improve ECs adhesion to a certain
substrate. As negative control, non-coated untreated scaffolds
were used. Plasma-modified SPCL fiber-mesh scaffolds were also
not coatedwith any protein.ConfluentHUVECswere trypsinized
and a suspension of 2 $ 105 cells was added per scaffold.
The samples were incubated under standard culture conditions
(37 "C, 5% CO2) for up to 7 days.
2.5. Characterization of cell viability, growth and morphology
Cell growth and viability were assessed by staining with the
fluorochrome dye calcein-AM and samples were visualized by
CLSM. HUVECs were cultured for 4 h, 3 days and 7 days
on the three materials studied: (i) Ar plasma-modified SPCL
fiber-mesh scaffold; (ii) positive control (untreated and fibro-
nectin-coated scaffold); and (iii) negative control (untreated and
non-coated scaffold). After each time point, the samples were
incubated in culture medium with 0.1 mM calcein-AM (Invi-
trogen, USA) for 10 min under standard culture conditions. For
CLSM (Leica TCS NT), and samples were prepared in mounting
medium (Natutec, Germany). SEM was used to evaluate cellular
morphology. Thus, after 7 days of culture samples were fixed
with 2% glutaraldehyde in 0.1 M sodium cacodylate buffer for 30
min and postfixed in 1% osmium tetroxide for 1 h. Subsequently,
samples were dehydrated with increasing ethanol concentrations,
dried with hexamethyldisilasane and sputter coated with gold.
2.6. Cell proliferation assay
The DNA content in the scaffolds lysate was determined using
the fluorescent picoGreen dsDNA quantification assay (Invi-
trogen, USA). The samples were thawed at room temperature
(RT) and sonicated for 15 min. A detailed description of the
assay is published elsewhere.27 The number of cells was calcu-
lated by correlation with the DNA content of a known number of
ECs. Triplicates were prepared for all materials and results were
presented as means % standard deviations. All the values were
analysed by a two-tailed Student’s t-test. Throughout the
following discussion, the differences were considered significant
if p < 0.05.
2.7. Gene and protein expression
The expression of markers related with ECs and angiogenesis,
namely PECAM-1 (CD31), VEGF-R1 and VE-cadherin, was
Table 1 Genes under evaluation, primers and PCR conditions
Name of gene
(GenBank
accession no.)
Product
size/bp
Annealing
temperature/"C
Primer pair
sequences
b-actin
(AB004047)
574 65 50AGCATTTGCGG
TGGACGATGGAG-30
50-GACCTGACTGACT
ACCTCATGA-30
PECAM-1 280 57 50- CAACAGACATGG
CAACAAGG-30
50- TTCTGGATGGTG
AAGTTG GC-30
VE-cadherin 452 57 50-GCTGAAGGAAAA
CCAGAAGAAGC-30
50-TCGTGATTATCCG
TGAGGGTAAAG-30
VEGF-R1 665 55 50–TCTCCTTAGGTG
GGTCTCC–30
50–CAGCTCAGCG
TGGTCGTAG–30
This journal is ª The Royal Society of Chemistry 2009 J. Mater. Chem., 2009, 19, 4091–4101 | 4093
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assessed at the mRNA level by semi-quantitative polymerase
chain reaction (PCR). Total RNA was extracted from HUVECs
cultured for 7 days on Ar plasma-modified SPCL scaffold, on the
positive control and on 2D tissue culture polystyrene (TCPs),
using the RNeasy Micro Kit (Qiagen, Germany). Equal amounts
of RNA (1 mg), measured by the NanoDrop microspectropho-
tometer, were reverse transcribed into cDNA (Omniscript RT
Kit, Qiagen, Germany). Afterwards, using gene-specific primer
sets (Table 1) the genes of interest were amplified by PCR with
Taq DNA polymerase Kit (Qiagen). The procedure for all the
genes included 35 cycles, consisting of an initial stage of 2 min of
denaturation at 94 "C, followed by 30 s of annealing (Table 1),
30 s of chain elongation at 72 "C and a final 10 min extension at
72 "C. Amplification products were separated by electrophoresis
on an agarose gel (0.8%) and stained with ethidium bromide. b-
actin was selected as the housekeeping gene.
The expression of PECAM-1, a major endothelial hallmark,
was evaluated at the cell–cell level by immunocytochemistry.
Hence, after 7 days of culture, the samples were fixed with
a solution of 2% paraformaldehyde for 30 min and washed with
PBS. Then, the cells were permeabilized with 0.1% Triton for 5
min and incubated with mouse anti-human PECAM-1 (1 : 50,
Dako, Denmark) for 1 h. After PBS washing, the secondary
antibody goat anti-mouse Alexa Fluor 488 (Invitrogen, USA)
was added and incubated for 1 h. Nuclei were counterstained
with 1 mg mL#1 Hoechst in PBS for 5 min. For CLSM obser-
vation SPCL fiber-mesh scaffolds were covered with mounting
medium. All immunostaining procedures were performed at RT.
3. Results
3.1. Physical and chemical characterization of Ar plasma
modified SPCL fiber-mesh scaffolds
During the contact of plasma with the biomaterial surface
different physical and chemical processes occur. These processes
can provoke changes in surface morphology and composition,
which in turn can affect protein and cell behaviour on themodified
material. Untreated materials presented a smooth surface with
minor irregularities (Fig. 1a and 2a), typically observed for
Fig. 1 Two-points line profile analysis for untreated (a) and plasma modified (b) SPCL.
Fig. 2 Optical profiler micrographs for SPCL fibers before (a) and after
(b) surface modification by Ar plasma (Mode: VSI, Mag: 107$).
4094 | J. Mater. Chem., 2009, 19, 4091–4101 This journal is ª The Royal Society of Chemistry 2009
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melt-processed polymers. Although the SEM analysis did not
show different morphology or surface texture after the applied
plasma treatment (pictures not shown) the results from optical
profiler demonstrated (Fig. 1b and 2b) a strong increase of the
surface roughness for the modified samples. An average rough-
ness of Ra ¼ 144.5 % 6.5 nm was measured for the untreated
samples, while this value was almost double for the modified ones
(Ra ¼ 236.5 % 18.5 nm). Moreover, not only roughness but also
a topography change was observed for the modified samples and
the characteristic laminated structure of untreated samples was
markedly reduced (Fig. 2).
On the other hand, the surface chemistry was also affected by
the applied treatment and significantly higher oxygen content
was measured for the modified surface compared to the
untreated one (Table 2). The measured C : O ratio together with
the TOF-SIMS spectrum (Fig. 3a) of the untreated material,
shows predominant presence of the synthetic component (PCL)
on the surface. Prominent peaks characteristic for the low mass
hydrocarbon fragments derived from the linear back bone of
PCL28 were detected at m/z 41, 55, 69, 97 as well as the monomer
(M + H)+ at m/z 115. The changes induced by the applied
treatment were confirmed by SIMS and less intensive peaks were
detected in the positive mass spectrum of modified samples
(Fig. 3b). The decrease of these peak intensities for the treated
material reflects the attack of the aliphatic sites and the subse-
quent loss/modification of these groups. The change in the
general appearance of the negative mass spectra (Fig. 4) as
a result of the treatment is typical29 for plasma-treated polymers.
The original polymer gives rise to a limited number of intense
peaks (Fig. 4a), referring to structural ions while plasma treat-
ment produces complex patterns with an intense peak on almost
Fig. 3 Positive ion TOF-SIMS spectra of SPCL fiber mesh before (a)
and after (b) plasma modification. The PCL peaks are marked.
Table 2 Calculated atomic concentrations of the building elements
(carbon and oxygen) of the studied materials
Material %C %O C : O ratio
Theoretical PCL 75.0 25.0 3.00
Theoretical SPCL 68.9 31.1 2.20
Untreated SPCL scaffolds 77.0 23.0 3.35
Plasma-modified SPCL scaffolds 72.2 27.8 2.60
Fig. 4 Negative ion TOF-SIMS spectra of SPCL fiber mesh before (a)
and after (b) plasma modification. Characteristic PCL peaks are marked.
This journal is ª The Royal Society of Chemistry 2009 J. Mater. Chem., 2009, 19, 4091–4101 | 4095
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every m/z (Fig. 4b), although the signal-to-noise ratio of indi-
vidual peaks remains good.
The contact angle values did not show any significant changes
in the hydrophilicity of the studied materials. The value of 83.56
% 5.34 measured for untreated material was almost the same as
that (81.76 % 2.09) measured after the applied treatment by
plasma. However, it must be noticed that because of the changes
in the surface roughness the effect of Cassie30must be present and
influences the measured values, especially those after modifica-
tion.
3.2. Protein adsorption on treated and untreated SPCL fiber-
mesh scaffolds
Two different adhesive proteins, Fn and Vn, were taken for the
studied materials. Fn was chosen for this study because it is
commonly used in a standard procedure, applied to improve the
adhesion of ECs. Vn is known for its ability to modulate
HUVEC spreading and migration. Moreover, a previous study31
on 2-dimensional starch-based materials has shown higher
adsorption affinity of Vn than Fn or albumin using unitary or
complex protein solutions. The micrographs presented on Fig. 5
confirmed the results obtained for 2D samples and higher
staining intensities for Vn can be observed in comparison with
those for Fn. Homogeneous protein distribution was similar for
both Fn-labelled untreated (Fig. 5a) and treated (Fig. 5b)
samples. In contrast, different protein distribution patterns were
observed for Vn adsorbed onto non-treated (Fig. 5c) and plasma-
modified scaffolds (Fig. 5d). In the latter case, vitronectin pre-
sented a heterogeneous distribution on the SPCL fiber surface,
with foci of high fluorescent signal on the Ar plasma-treated
scaffolds.
3.3. Influence of Ar plasma treatment on cell adhesion, viability
and morphology
Viable ECs were detected on the surface of Ar plasma-modified
scaffolds after 4 hours of cell seeding (Fig. 6a). The cells were
homogeneously distributed on the scaffold and presented
a morphology that reflects an early stage of attachment. On the
positive control, i.e., untreated scaffolds pre-coated with fibro-
nectin, viable ECs had also adhered on the surface and the cells
exhibited a well-developed spread morphology (Fig. 6b). In
contrast, only a few cells exhibiting a rounded-up morphology
were observed on the negative control (Fig. 6c). After 7 days of
culture, ECs formed a complete monolayer on the surface of the
plasma-modified scaffolds, as well as on the positive control
(Fig. 6d and 6e). In addition, the morphological differences
observed for these two samples at the earlier time points vanished
after 7 days of culture. On the other hand, on the negative
control, only a few cells were detectable on the scaffold surface
(Fig. 6f). Fig. 7 reveals further details of EC morphology on the
plasma-modified scaffold and on the positive control after 7 days
of culture. ECs exhibited the typical flattened and well-spread
morphology in both samples. Moreover, the intimate contact
established between neighbouring cells led to a compact and
Fig. 5 Untreated (a, c) and plasma-modified (b, d) SPCL fiber meshes
immunolabeled for Fn (a–b) and Vn (c–d) after 1 h immersion in culture
medium supplemented with 20% serum. Note the markedly increased
adsorption of Vn compared to Fn.
Fig. 6 Calcein-AM viability assay of HUVEC grown on plasma-
modified (a, d), Fn-coated (b, e) and untreated (c, f) scaffolds for 4 h (left
column) and 7 days (right column). The value of the scale bars is 600 mm.
4096 | J. Mater. Chem., 2009, 19, 4091–4101 This journal is ª The Royal Society of Chemistry 2009
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uniform cell distribution that covered the individual fibers of the
scaffolds.
3.4. EC proliferation profile on the SPCL fiber mesh scaffolds
DNA quantification (Fig. 8) showed that HUVECs were able to
proliferate when they were cultured on plasma-modified or
fibronectin-coated fiber meshes. From day 3 to 7 increased cell
proliferation was observed for these two materials and this
difference was significant for the plasma-modified material. On
the contrary, the negative control sustained the growth of very
few cells, and after 7 days of culture this value dropped below the
method’s detection limit. It must be noted that the highest
number of cells was observed on the plasma-modified scaffolds.
This pattern was more apparent after longer culture times when
the proliferation rate on plasma-treated scaffolds was signifi-
cantly higher as compared to the positive control.
3.5. Expression of endothelial markers
To confirm the maintenance of the endothelial phenotype and of
markers involved in angiogenesis, total RNA was extracted from
EC-seeded scaffolds and assayed by RT-PCR. The expression of
important cell adhesion molecules such as PECAM-1 and VE-
cadherin was retained in both plasma-treated and positive
control scaffolds (Fig. 9). Furthermore, RT-PCR revealed the
expression of the receptor for the most potent angiogenic growth
factor, vascular endothelial growth factor (VEGF-R1). On TCP,
the optimal surface for tissue culture, used as 2D control, ECs
were also capable of producing mRNA that encodes for the three
markers under study.
PECAM-1 expression was also assessed at the single-cell level
by immunocytochemistry. This marker was depicted as a well-
defined green ring around neighbouring cells on the surface of
plasma-treated and on positive control SPCL fiber-mesh scaf-
folds (Fig. 10). In fact, the expression of this adhesion molecule
involved in endothelial cell–cell interaction was similar for these
two materials and represents the distribution pattern for physi-
ologically quiescent, that is, non-activated ECs.
Discussion
In a simplistic way, bone can be described as a three-component
tissue: (i) a mineralized matrix, supplied by (ii) a complex
vascular network and orchestrated by (iii) several cell types that
release a multitude of growth factors. Therefore, in a strategy
aimed at regeneration of bone tissue, these components must
be considered. The bulk structure of the scaffold must take
into account the mechanical function of the tissue, while the
architecture must allow the penetration of a functional vascular
plexus and the scaffold’s surface must be compatible with the
Fig. 7 SEM micrographs of HUVEC grown on plasma-modified scaf-
folds (a) and on the positive (fibronectin-coated scaffolds) control (b) for
7 days.
Fig. 8 Cell proliferation of HUVEC growing on plasma-modified
scaffold, positive and negative control. The number of cells was deter-
mined by DNA quantification. Error bars represent means % SD.
*Significantly different t-Test, p < 0.05.
Fig. 9 Expression of endothelial markers at the mRNA level (RT-PCR)
for HUVEC grown on tissue culture polystyrene, plasma-treated, and
fibronectin-coated SPCL scaffolds.
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different cells that build up the tissue. SPCL fiber-mesh struc-
tures have been proposed as a scaffolding material for bone
tissue engineering.21,22,32 Previous studies have shown the ability
of these scaffolds to promote adhesion of bone marrow cells,
their differentiation into an osteoblast lineage accompanied by
the deposition of a mineralized matrix and production of several
growth factors involved in osteogenesis and angiogenesis.21,23,33
Moreover, regarding the importance of ECs in angiogenesis,
other work from our group demonstrates the ability of
this material to support the adhesion, proliferation and
maintenance of the phenotypic expression of ECs.24 The surface
of SPCL fiber-mesh scaffold requires a pre-coating with an
adhesive protein in order to sustain EC adhesion similar to that
observed by a large number of other polymeric substrates34–36
However, protein adsorption is a process difficult to control
and several obstacles such as low stability to sterilization
processes, heat treatment and pH variation, storage and
conformation shifting37,38 are associated with its application.
Therefore, based on the results of our studies, we propose
that plasma surface modification of SPCL fiber-mesh
scaffolds can be used as an alternative approach to render the
surface compatible for EC adhesion. The described methodology
has the advantage that it obviates the need for protein pre-
coating and can be simultaneously used as a cost-effective
method for sterilization.
The interplay between the surface features changed by plasma
modification and the adsorption of proteins may subsequently
affect cell behaviour via:
(i) Increasing the surface area available for protein adsorption
by etching processes, typically ongoing during the plasma
treatment;
(ii) Modulation of the surface chemistry, i.e. the physical
bonds on the surface/proteins. Although a straightforward
relation can not always be established, EC adhesion is often
associated with groups such as hydroxyl (–OH) or carboxyl
(–COOH).39,40 Furthermore, enhanced EC proliferation and
spreading in response to increased oxygen content has also been
shown in previous studies41,42 on 2D samples prepared from
synthetic polymers.
(iii) Alternation of the surface charge. Negatively charged
groups have shown43–46 positive effects on cell adhesion and
growth and this is attributed to the favourable protein confor-
mation on these surfaces. The polarity of these groups allows
formation of additional hydrogen bonds with the proteins, which
will keep them fixed onto the surface. From the oxygen con-
taining functional groups, COOH are the ones that influence
mostly the growth of ECs47,48
When physical plasma comes into contact with the biomaterial
surface, the activated species are accelerated towards the
substrate by the applied electrical field. Since some parts of the
surfaces are exposed to energies higher than the bonding energy
of polymers, these parts undergo chain scission.49,50 Chain scis-
sion processes will then initiate various events. Surface degra-
dation or so-called etching is one of the effects that can be
observed. This effect depends on the used power, which deter-
mines the acceleration of the active species towards the material
surface, as well as on the time during which the material is
exposed to this bombarding with active species. Surface etching
was observed at the used conditions for SPCL fiber-mesh scaf-
folds. Both roughness and topography were altered by the
applied treatment as shown by optical profilometry. Hence,
alterations in cellular/protein behaviour could be expected as
a response to the introduced changes of the surface morphology.
The higher roughness is associated with a higher surface area and
therefore an increased quantity of adsorbed proteins as well as
a higher number of cells on the modified surface must be
observed. On the other hand, the chain scission was confirmed by
TOF-SIMS, where the intensity of the characteristic polymer
peaks decreased for the plasma treated material. Chain scission
results in the formation of highly reactive radicals on the surface.
Those radicals can recombine (e.g. crosslinking reactions) or
react with the other species such as oxygen from the air. Those
processes were confirmed by both XPS and TOF-SIMS analyses
of the surface chemical composition of the studied materials.
XPS showed higher oxygen concentration for the modified
materials. Additionally, the negative mass spectrum of plasma
treated scaffolds was abundant in new, low intensity peaks,
which also reveal ongoing functionalisation. Changing of the
surface chemistry in turn is expected to modulate protein
Fig. 10 PECAM-1 staining (green fluorescence) of ECs on plasma-
modified SPCL scaffold (a) and on positive control (b) cultured for 7
days. Nuclei were counterstained with Hoechst (blue fluorescence). The
value of the scale bars is 150 mm.
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adsorption. Depending on the nature of the established protein–
surface interactions, surfaces can modulate adhesion and cell
biochemical mechanisms such as those involved in cell differen-
tiation. Protein-containing solutions can be used as a source of
biomolecules that will further bridge and affect cell adhesion.
The analysis of the adsorption of the cell-adhesive molecules, Fn
and Vn, showed some differences in their comparative adsorp-
tion ability as well for the comparison of modified and untreated
samples. Although a different affinity of Fn and Vn to 2-
dimensional SPCL surfaces was previously observed,31 the
analysis of the adsorption of these molecules on 3D starch-based
scaffolds following argon surface modification has not been
demonstrated. An important result of the present study is the
indication that Vn distribution follows the surface morphology
of the studied fibers and can be altered by changing of their
surface pattern. Before treatment, a laminated distribution of Fn
was observed. This same morphology was also shown by optical
profiler for the untreated scaffolds. After plasma treatment the
laminated structure was lost and in turn the Vn distribution
pattern was affected, analogous to the changed morphology of
SPCL scaffolds. Vn is a biomolecule known to control and
modulate EC spreading and migration and is well-characterized
as a modulator of the cytoskeleton.51,52 On the other hand, no
difference was observed for Fn. However, this is not surprising,
as it is reported that in complex protein solutions Fn interacts
with the available cell non-adhesive molecules,53 which reduces
its competitiveness and explains its failure to adsorb on to the
substrate in the presence of other serum proteins.54 As a result, in
bovine plasma and fresh serum higher cell activity is associated
with Vn but not with Fn.
Cell adhesion is the ultimate functional result of both the
material’s surface physicochemical properties and its protein
adsorption. The changed physicochemical properties of the
underlying substrate can modulate the EC behaviour by affecting
the proteins’ conformation and orientation and hence enhancing
the anchorage strength to the substrate. Additionally, the surface
properties of treated scaffolds might also stabilize the proteins
secreted and deposited by ECs aimed to constitute the basement
membrane.48,55 In vitro studies with human ECs revealed that
uncoated and non-modified SPCL fiber-mesh scaffolds displayed
substantially reduced cellular adhesion. However, cell attach-
ment to SPCL scaffolds was significantly enhanced when physi-
cally adsorbed fibronectin, a standard procedure in endothelial
culture, was used. Moreover, ECs on the positive controls
remained viable and also proliferated during the 7 days of
culture. When the SPCL surface was treated by Ar plasma the
surface was tailored for EC adhesion, obviating the need for
protein pre-coating. Furthermore, the proliferation level of ECs
on Ar plasma-treated scaffolds was significantly higher than on
the positive control. Hence, plasma treatment not only promoted
the initial stages of cell attachment but also triggered the EC
metabolic activity.
Protein-mediated interactions established between cells and
substrate not only provide anchorage sites for cell adhesion but
also dictate important cell parameters such as morphology,
proliferation, migration, differentiation and responsiveness.56
Therefore, the effect of the performed modification on the
morphology and phenotypic/genotypic expression of ECs was
assessed. Morphology mirrors cell–substrate interactions in so
far as altered orientation of adsorbed proteins will modulate
cellular integrin receptor binding and consequently this will be
reflected in cytoskeletal re-arrangement. Changing the surface of
SPCL fiber-mesh scaffolds by Ar plasma did not affect the
typical flattened EC morphology. This is a positive indicator of
cellular mechanical coupling to the underlying substrate.
Regarding endothelial markers, the expression of VEFGR-1 at
the gene level was confirmed for plasma-treated scaffolds as well
as on positive and TCP controls. VEGFR-1 is a key gene not
only involved in angiogenesis but also associated with monocyte
chemotaxis and with recruitment of bone marrow-derived
progenitor cells.57 Another gene whose expression was main-
tained on the modified scaffold was VE-cadherin, an essential cell
adhesion molecule in establishing and maintaining endothelial
integrity. The anchorage of cadherins to the cytoskeleton and
their clustering are indispensable for the development of strong
and rigid cell–cell adhesions.58 Additionally, PECAM-1, one of
the hallmarks of the endothelium is a crucial molecule for
homotypic adhesion involved in the maintenance of endothelial
integrity.59 The expression of PECAM-1 was observed on
plasma-modified and fibronectin-coated scaffolds at both
mRNA and single-cell protein level. Furthermore, cell–cell
adhesion was detected at the cell borders, which is a good indi-
cation of the non-activated status of interactions between
neighbouring cells. These overall results indicate that ECs
maintained their differentiated phenotype and the integrity of
endothelial monolayer on plasma-modified scaffolds.
Conclusions
Argon plasma treatment was shown to be an effective method to
modify the surface of a 3D starch-based scaffold for EC adhe-
sion. Cell attachment and expression of endothelial markers on
plasma-treated SPCL fiber-mesh scaffolds was comparable to the
scaffold pre-coated with fibronectin, used as a positive control.
However, higher proliferation rates were observed on plasma-
modified scaffolds. This improved overall biological outcome is
the result of novel protein–surface interactions generated by
plasma treatment. Increased surface roughness, altered surface
pattern and changed surface chemistry were the main physico-
chemical changes demonstrated on the SPCL fiber-mesh scaffold
surface. Consequently, these properties modulate protein
adsorption as indicated by the different adsorption profile of the
adhesive protein vitronectin.
Finally, argon plasma treatment renders the surface compat-
ible for ECs and this is a significant step forward towards the
improvement of constructs for vascularization. Furthermore, in
addition to eliminating the need for pre-coating with proteins
and the respective drawbacks associated with this methodology,
plasma treatment does not affect the scaffold’s bulk structure
and can simultaneously be used as an effective sterilization
method. Starch-based scaffolds treated by Ar plasma were
shown to be a good support to use on bone tissue engineering,
where vascularization is a main requirement.
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